BDP8900 is a potent and selective inhibitor of myotonic dystrophy-related Cdc42-binding kinases (MRCKalpha and MRCKbeta). BDP8900 reduces substrate phosphorylation, leading to morphological changes, motility inhibition and invasiveness of cancer cells[1].
Molecular Weight:
353.48
CAS Number:
[2226507-05-5]
Formula:
C19H23N5S
Target:
Cdc42-binding kinase
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
